Stocks
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -2 672% | -1 435% | -1 151% | -864.3% | -712.0% | |||
| Changes by years, y/y, % | +160pp | +1 237pp | +284pp | +287pp | +40.0% | ||||
Agios Pharmaceuticals. EBITDA margin, %
Agios Pharmaceuticals. EBITDA margin, changes, pp
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -1 207% | -1 010% | -896.7% | -602.6% | -523.8% | -712.0% | |
| Changes by years, y/y, % | -99pp | +200pp | +235pp | +550pp | +684pp | |||
| Changes by quarters, q/q, % | -55pp | +197pp | +113pp | +294pp | +79pp | |||
